CClinicalTrials.gg
RecruitingNCT07797296MENO-ROUpdated Sep 1, 2026

Predictors of Religious Orientation Attitudes in Menopausal Women

An observational study in Menopause, Menopausal Syndrome and Sexual Dysfunction, sponsored by KTO Karatay University. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 49 Years to 59 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-01.

Sponsored by KTO Karatay University · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
97
Ages
49 Years to 59 Years
Sex
Female
01

Study summary

This descriptive, cross-sectional study examines whether the severity of menopausal symptoms and attitudes toward sexual myths predict intrinsic religious orientation in menopausal women. Menopause is a multidimensional transition with biological, psychological, social and spiritual aspects, and in societies with a strong cultural and religious fabric women may draw on religious orientation as a coping and meaning-making resource. Participants are healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease, recruited in Konya, Turkey. Data are collected face to face using a personal information form, the Menopause Rating Scale, the Intrinsic Religious Orientation Scale and the Sexual Myths Scale, and analysed with multiple regression.

Read the detailed description

Background:

Menopause is a multidimensional transition in a woman's life with biological, psychological, social and spiritual dimensions. With increasing life expectancy, women spend roughly a third of their lives in the menopausal period. The decline in oestrogen is associated with hot flushes, sleep disturbance, mood fluctuations and sexual dysfunction, which can adversely affect quality of life. The literature emphasises that the menopause experience is shaped not only biologically but also by sociocultural factors and religious beliefs, and that religious and spiritual orientation can increase psychological resilience and reduce anxiety and stress. Sexual dysfunction is highly prevalent in this period, and sexuality is closely linked to lifestyle, cultural roles, religious beliefs and societal myths; low sexual awareness and adoption of sexual myths may intensify the perceived severity of menopausal symptoms.

Aim:

To determine the predictive effect of the physical and psychological symptoms of menopause and of attitudes toward sexual myths on the intrinsic religious orientation of menopausal women.

Design and setting:

Descriptive, cross-sectional design. The study population comprises healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey. The sample consists of women who meet the inclusion criteria and volunteer to participate.

Sample size:

Calculated with G*Power 3. For a linear multiple regression model with a medium effect size of 0.15, power of 0.95 and a Type I error of 0.05, a minimum of 89 participants is required. Allowing for a possible 10 percent data loss, 97 participants are planned.

Measures:

A personal information form (15 items covering sociodemographic and obstetric characteristics), the Menopause Rating Scale (MRS), the Intrinsic Religious Orientation Scale and the Sexual Myths Scale. Written informed consent is obtained; author permissions for the scales are obtained by email. Data are collected face to face.

Statistical analysis:

Analyses are performed with IBM SPSS Statistics v29.0. Normality is assessed with visual and analytical methods (Kolmogorov-Smirnov test). Descriptive statistics are reported as mean and standard deviation or median (minimum to maximum) as appropriate. Multiple regression models are built to estimate regression coefficients and 95 percent confidence intervals for the relationships between religious orientation and age, number of pregnancies, menopause duration, menopause symptom severity and sexual myths. Group comparisons use the Mann-Whitney U and Kruskal-Wallis tests where appropriate. Significance is set at p less than 0.05.

Ethics:

Institutional permission and ethics approval will be obtained from the Non-Drug and Non-Medical Device Research Ethics Board of KTO Karatay University before the study begins. Written informed consent is obtained from all participants.

02

Conditions studied

  • Menopause
  • Menopausal Syndrome
  • Sexual Dysfunction

Keywords

  • Menopause
  • Religious orientation
  • Spirituality
  • Menopausal symptoms
  • Sexual myths
  • Women's health
  • Cross-sectional study
03

Who can participate

Ages eligible
49 Years to 59 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic health problem, presenting to a health facility in Konya, Turkey, who volunteer and provide written informed consent.

Inclusion criteria

  • Woman aged 49 to 59 years
  • Diagnosis of menopause
  • No chronic health problem
  • Volunteers to participate and provides written informed consent

Exclusion criteria

Exclusion Criteria:

* Presence of a chronic disease (e.g. cardiac disease, diabetes, hypertension)

04

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
97 participants (estimated)
Patient registry
No

Groups and cohorts

  • Menopausal women aged 49 to 59

    Healthy women aged 49 to 59 with a diagnosis of menopause and no chronic disease (such as cardiac disease, diabetes or hypertension), recruited in Konya, Turkey, who volunteer to participate. Participants complete a single battery of self-report scales collected face to face; no intervention is applied.

05

What researchers measure

Primary outcomes

  1. Intrinsic religious orientation (Intrinsic Religious Orientation Scale)

    The Intrinsic Religious Orientation Scale (Hoge, 1972; Turkish standardisation by Karaca, 2001) contains 10 items measuring intrinsic religious motivation. Seven items are positively worded and three are negatively worded and reverse coded. Items are rated on a 5-point Likert format scored from 0 (weakest) to 4 (strongest), giving a total score of 0 to 40, with higher scores indicating stronger intrinsic religious orientation.

    Time frame: Single assessment at enrollment (Day 1)

Secondary outcomes

  1. Menopausal symptom severity (Menopause Rating Scale, MRS)

    The Menopause Rating Scale (Schneider et al., 2000; Turkish adaptation by Can Gurkan, 2005) is an 11-item scale with three subscales: somatic complaints, psychological complaints and urogenital complaints. Each item is rated on a 5-point scale from 0 (none) to 4 (very severe), giving a total score of 0 to 44, with higher scores indicating greater symptom severity.

    Time frame: Single assessment at enrollment (Day 1)

  2. Sexual myths (Sexual Myths Scale, SMS)

    The Sexual Myths Scale (Golbasi et al., 2016) is a 28-item, 5-point Likert scale with eight subscales (sexual orientation, gender, age and sexuality, sexual behaviour, masturbation, sexual violence, sexual intercourse and sexual satisfaction). The total score ranges from 28 to 140, with higher scores indicating a greater likelihood of holding sexual myths.

    Time frame: Single assessment at enrollment (Day 1)

06

Study locations

1 of 1 sites recruiting
  • Recruitment site (to be specified), Konya
    Konya, Turkey (Türkiye)
    • Aslihan Turan · Contact
    • Aslihan Turan · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07797296
Lead sponsor
KTO Karatay University
Responsible party
Aslıhan Turan (Principal Investigator, KTO Karatay University) — Principal investigator
First posted
Sep 1, 2026
Start date
Aug 26, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Feb 2, 2027 (estimated)
Last update
Sep 1, 2026

Study contacts

Hasan Gercek, PhD
Contact
hasan.gercek@acibadem.edu.tr
+90 542 648 8455
Aslihan Turan
principal investigator · KTO Karatay University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion